{"@id":"https://bioecon.ru/technology/chelation-therapy-for-metal-overload/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://en.bioecon.ru/technology/chelation-therapy-for-metal-overload/","json":"https://en.bioecon.ru/api/v1/technology/chelation-therapy-for-metal-overload/index.json"},"id":"chelation-therapy-for-metal-overload","industries":["pharma","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/epse-oy/","https://bioecon.ru/companies/retro-biosciences/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/johnson-johnson/","https://bioecon.ru/companies/bioviva/","https://bioecon.ru/companies/algalif/","https://bioecon.ru/companies/jindalai-environmental/","https://bioecon.ru/companies/minicircle/","https://bioecon.ru/companies/metso/"]},"maturity":7,"name":"Chelation Therapy for Metal Overload","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"High-affinity multidentate design"},{"n":2,"title":"Trace mineral selectivity"},{"n":3,"title":"Organ redistribution and urinary clearance"},{"n":4,"title":"Clinical disease reversal"}],"summary":"Orally bioavailable synthetic chelating agents exhibiting thermodynamic stability constants (log K \u003e 25) for toxic free copper or iron, promoting physiological urinary excretion without depleting essential trace minerals in Wilson's disease and metal-induced neurodegeneration.","url":"/technology/chelation-therapy-for-metal-overload/","verified":"2026-11-22"}